Katharina Reichenbacher

This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2017-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katharina Reichenbacher. Retrieved from https://idiyas.com/inventor/katharina-reichenbacher

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)

Company Filing History:

4 out of 2,405

Merck Sharp + Dohme Corp.

patents

Years Active: 2017-2019

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10442829 - Forms of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate (2019-10-15),

2. 10065947 - Forms of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate (2018-09-04),

3. 9988406 - Forms of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate (2018-06-05),

4. 9624250 - Forms of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate (2017-04-18),

Title: Katharina Reichenbacher: Innovator in Antibiotic Development

Introduction

Katharina Reichenbacher is a prominent inventor based in Riehen, Switzerland. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antibiotics. With a total of 4 patents to her name, her work has the potential to impact healthcare positively.

Latest Patents

Her latest patents focus on the crystalline form of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate. These patents detail methods of creating this crystalline form and highlight its usefulness as an antibiotic. The derivatives of her invention demonstrate potent antibacterial activity against various human and animal pathogens, including Gram-positive bacteria such as Staphylococci, Enterococci, and Streptococci, as well as anaerobic microorganisms and acid-resistant microorganisms. The compositions derived from her work may serve as effective antibiotics.

Career Highlights

Katharina Reichenbacher is associated with Merck Sharp & Dohme Corporation, where she continues to innovate in the pharmaceutical sector. Her research and development efforts are crucial in addressing the growing need for effective antibiotics.

Collaborations

She has collaborated with notable coworkers, including Robert J Duguid and Jacqueline A Ware, contributing to a dynamic research environment that fosters innovation.

Conclusion

Katharina Reichenbacher's work in antibiotic development showcases her dedication to improving healthcare through innovative solutions. Her contributions are vital in the ongoing fight against bacterial infections.

Profile summary based on public USPTO records.